Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease Psychosis”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Early research (Phase 1)Looking for participantsNCT07230652
What this trial is testing

MAD Study to Evaluate the Safety and Tolerability of LY03020

Who this might be right for
SchizophreniaAlzheimer's Disease Psychosis
Luye Pharma Group Ltd. 40
Post-approval studies (Phase 4)Study completedNCT01119638
What this trial is testing

Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone

Who this might be right for
AgitationPsychosisAlzheimer's Disease
Abarbanel Mental Health Center 40
Large-scale testing (Phase 3)Looking for participantsNCT06585787
What this trial is testing

Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Who this might be right for
Alzheimer Disease
Karuna Therapeutics 406
Not applicableStudy completedNCT02453763
What this trial is testing

In Vivo Imaging of Therapeutic Electric Current Flow

Who this might be right for
Parkinson DiseaseEpilepsyAlzheimer's Disease+4 more
University of Florida 17
Not applicableLooking for participantsNCT05245903
What this trial is testing

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Who this might be right for
Alzheimer DiseaseDementia AlzheimersDementia+7 more
Mclean Hospital 40
Early research (Phase 1)Study completedNCT02392468
What this trial is testing

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

Who this might be right for
SchizophreniaAlzheimer Disease
Boehringer Ingelheim 61
Post-approval studies (Phase 4)Study completedNCT00417482
What this trial is testing

Antipsychotic Discontinuation in Alzheimer's Disease

Who this might be right for
Alzheimer DiseasePsychotic DisordersAgitation+1 more
New York State Psychiatric Institute 180
Large-scale testing (Phase 3)Study completedNCT01438060
What this trial is testing

Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Who this might be right for
Dementia, Alzheimer Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 232
Not applicableUnknownNCT03807388
What this trial is testing

ReMindCare App for Patients From First Episode of Psychosis Unit.

Who this might be right for
PsychosisSchizophreniaPsychotic Disorders+4 more
Instituto de Investigacion Sanitaria INCLIVA 140
Large-scale testing (Phase 3)Study completedNCT00034762
What this trial is testing

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer DiseaseMental Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Large-scale testing (Phase 3)UnknownNCT00190021
What this trial is testing

Donepezil Treatment of Psychotic Symptoms in Dementia Patients

Who this might be right for
Dementia of Alzheimer Type
Beersheva Mental Health Center 80
Not applicableLooking for participantsNCT04946916
What this trial is testing

Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease

Who this might be right for
SchizophreniaBipolar DisorderAlzheimer Disease+1 more
Hôpital le Vinatier 120
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Not applicableEnrolling By InvitationNCT07314190
What this trial is testing

Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitorign of Patients With a Neurodegenerative Disease or Mental Disorder

Who this might be right for
Alzheimer DiseaseDementia With Lewy Bodies (DLB)Frontotemporal Dementia (FTD)+4 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,799
Not applicableUnknownNCT02439099
What this trial is testing

Retinoic Acid Homeostasis in Neuropsychiatric Diseases

Who this might be right for
Major DepressionAlzheimer's DiseaseAlcoholism+1 more
Charite University, Berlin, Germany 200
Early research (Phase 1)Study completedNCT00795730
What this trial is testing

Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

Who this might be right for
Alzheimer DiseaseHealthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer 24
Post-approval studies (Phase 4)Study completedNCT00009217
What this trial is testing

Treatment of Behavioral Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePsychosisAgitation
New York State Psychiatric Institute 44
Testing effectiveness (Phase 2)Looking for participantsNCT06540833
What this trial is testing

Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Intra-Cellular Therapies, Inc. 370
Large-scale testing (Phase 3)Looking for participantsNCT05980949
What this trial is testing

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics 800
Large-scale testing (Phase 3)Study completedNCT01922258
What this trial is testing

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 270
Load More Results